AK135 in Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

NCT06860789 · clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
85
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Akeso